The company has completed recruitment for its clinical trial in dogs with chronic pain, marking a key milestone toward the clinical validation of its therapeutic solution.

https://www.linkedin.com/posts/xeptivatherapeutics_se-cierra-una-etapa-muy-importante-finalizamos-activity-7419455279265853440-YC7M/?utm_source=ithinkvc.beehiiv.com&utm_medium=newsletter&utm_campaign=ithink-vc-q1-2026-update-venture-portfolio-ecosystem-highlights&_bhlid=33ededa71ccf8aef83e753a12ff3072dd9c42278